The Adenosine Injection, cataloged under National Stock Number 6505-01-666-0343, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-666-0343 |
| Primary Part Number | NDC25021-0301-68 |
| Item Name | Adenosine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 4.0 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | SYRINGE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE AND DO NOT REFRIGERATE |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 3.0 MILLIGRAMS ADENOSINE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC25021-0301-68 PRIMARY | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc (USA) |
| NDC25021-0301-68 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| Reference | Meaning |
|---|---|
| 1482108 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM173708 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-666-0343 is a Adenosine Injection, manufactured by Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-666-0343 has 2 manufacturer part numbers on file: NDC25021-0301-68 (Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc), NDC25021-0301-68 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office).
Key specifications for NDC25021-0301-68: Primary Container Content Quantity: 4.0 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: SYRINGE; Special Features: 3MG/ML ACTIVE INGREDIENT ADENOSINE 4ML PREFILLED SYRINGE; PRESERVATIVE FREE; (12MG/4ML)PG 10'S NEEDLELESS; STORE AT USP CONTROLLED ROOM TEMPERATURE 20 TO 25 DEG C(68 TO 77 DEG F), DO NOT REFRIGERATE; DO NOT FREEZE; FOR RAPID BOLUS INTRAVENOUS USE. DEGC. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.